In this issue

Cancer Biology & Therapy
Volume 14, Issue 5
May 2013
View current issue
About the cover
The cover image is a photomicrograph depicting in situ zymography on fresh frozen section from a 35-day-old MCF10DCIS.com xenograft, a mouse model of human...
Continue reading

Editor-in-Chief

Wafik S. El-Deiry, M.D., Ph.D.

Penn State University, Hershey, PA

Email the Managing Editor, Thomas Ostmeyer.
Print ISSN: 1538-4047
Online ISSN: 1555-8576
Abstracted/Indexed In:
Medline/PubMed, Scopus and in the Web of Science.

Open Access in Cancer Biology & Therapy

Cancer Biology & Therapy offers a highly competitive open access fee for authors who wish for free access to and distribution of published articles. Authors retain copyright of their work by utilizing a Creative Commons attribution license. Open Access papers will be submitted to PubMed Central immediately upon final publication of each issue.

The cost to make an original research paper OA is $750.00 USD.

For all other types of papers, the OA fee is $500.00 USD.

Find us on Facebook

CB&T News and Updates

Cancer News Daily - an aggregate news source of the most up-to-date cancer research

Download a PowerPoint presentation about Cancer Biology & Therapy. Created 04.16.2011, 5.9 MB

Cancer Biology & Therapy Editor-in-Chief, Wafik El-Deiry, named as Chief of Hematology/Oncology at Penn State; 04.2010

Update on guidelines for duplicate publications and guidelines for plagiarism; 05.15.2009

Plagiarism is Not Acceptable in Science or for Cancer Biology & Therapy; 06.2005

CB&T archives (published online for one year or longer) are freely available to all users. Full-text access is available via a link on the abstract page of each paper.

Most Popular Downloads

01 Apr 13
Mammaglobin peptide as a novel biomarker for breast cancer detection
Julie M. Galvis-Jiménez, Hernando Curtidor, Manuel A. Patarroyo, et al.
01 Jun 12
Combination of HDAC and topoisomerase inhibitors in small cell lung cancer
Jhanelle Gray, Christopher L. Cubitt, Shumin Zhang, et al.
01 Apr 13
Metabolic reprogramming of the immune response in the tumor microenvironment
Susan A. McCarthy, R. Allan Mufson, Edward J. Pearce, et al.

Landes Highlights

Relevant articles recently published in other Landes journals

The role of Snail in prostate cancer. Smith and Odero-Marah. Cell Adhesion & Migration 6(5): September/October 2012. (Review)

Heterogeneous epigenetic regulation of TIMP3 in prostate cancer. Shinojima et al. Epigenetics 7(11); November 2012.

Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls. Sturgeon et al. Epigenetics 7(11); November 2012.

Study on the association of helicobacter species with viral hepatitis-induced hepatocellular carcinoma. Krüttgen et al. Gut Microbes 3(3). May/June 2012.

Understanding the role of stromal fibroblasts in cancer progression. Tripathi, Billet and Bhowmick. Cell Adhesion & Migration 6(3). May/June 2012. Review.

Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion. Li et al. Epigenetics 7(8). August 2012.

 

 

Advertisements